0B68 Werner-Wasik, Maria - Thomas Jefferson University - Thomas Jefferson University
mxw135

Maria Werner-Wasik, MD

Contact Dr. Werner-Wasik

111 South 11th Street
Room G-301, Bodine Center
Philadelphia, PA 19107

(215) 955-6702
(215) 955-0412 fax

Most Recent Peer-reviewed Publications

  1. Dose-response relationship with clinical outcome for lung stereotactic body radiotherapy (SBRT) delivered via online image guidance
  2. A randomized trial of bevacizumab for newly diagnosed glioblastoma
  3. Targeting metabolism with a ketogenic diet during the treatment of glioblastoma multiforme
  4. Net clinical benefit analysis of radiation therapy oncology group 0525: a phase III trial comparing conventional adjuvant temozolomide with dose-intensive temozolomide in patients with newly diagnosed glioblastoma.
  5. Identification of a KRAS mutation in a patient with non-small cell lung cancer treated with chemoradiotherapy and panitumumab
  6. Reduced-dose fractionated stereotactic radiotherapy for acoustic neuromas: Maintenance of tumor control with improved hearing preservation
  7. Decline in tested and self-reported cognitive functioning after prophylactic cranial irradiation for lung cancer: Pooled secondary analysis of radiation therapy oncology group randomized trials 0212 and 0214
  8. The addition of amifostine to carboplatin and paclitaxel based chemoradiation in locally advanced non-small cell lung cancer: Long-term follow-up of Radiation Therapy Oncology Group (RTOG) randomized trial 9801
  9. Impact of a radiation oncology elective on the careers of young physicians: Update on a prospective cohort study
  10. ALK inhibitor PF02341066 (Crizotinib) increases sensitivity to radiation in non-small cell lung cancer expressing EML4-ALK
  11. Radiosurgery for the treatment of dominant hemisphere periventricular heterotopia and intractable epilepsy in a series of three patients
  12. A phase 3 trial of whole brain radiation therapy and stereotactic radiosurgery alone versus WBRT and SRS with temozolomide or erlotinib for non-small cell lung cancer and 1 to 3 brain metastases: Radiation therapy oncology group 0320
  13. Lack of a dose-effect relationship for pulmonary function changes after stereotactic body radiation therapy for early-stage non-small cell lung cancer
  14. Predictors of radiation oncology resident research productivity
  15. Treatment-related acute esophagitis 0A34 for patients with locoregionally advanced non-small cell lung cancer treated with involved-field radiotherapy and concurrent chemotherapy
  16. A phase i study of the combination of sorafenib with temozolomide and radiation therapy for the treatment of primary and recurrent high-grade gliomas
  17. Intensity-modulated radiation therapy and volumetric-modulated arc therapy for adult craniospinal irradiation-A comparison with traditional techniques
  18. Fractionated stereotactic radiation therapy improves cranial neuropathies in patients with skull base meningiomas: A retrospective cohort study
  19. Evaluating changes in radiation treatment volumes from post-operative to same-day planning MRI in High-grade gliomas
  20. Modeling local control after hypofractionated stereotactic body radiation therapy for stage I non-small cell lung cancer: A report from the Elekta Collaborative Lung Research Group
0